openPR Logo
Press release

Lumbosacral Radicular Pain Market Growth Anticipated by 2032 | Companies includes Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Teva BrandedPharmaceutical Products R&D, Cephalon

09-11-2024 02:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Lumbosacral Radicular Pain Market

Lumbosacral Radicular Pain Market

The approval of emerging gene therapies will mark a significant milestone for patients enduring lumbosacral radicular pain.
According to the latest report, "Lumbosacral Radicular Pain Market Insights, Epidemiology, and Market Forecast 2032 [https://www.delveinsight.com/report-store/lumbosacral-radicular-pain-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" from DelveInsight, the market for lumbosacral radicular pain is expected to experience significant growth from 2019 to 2032.

The market dynamics are projected to evolve due to increasing interest from pharmaceutical companies in developing new treatments, advancements in diagnostic methods, and the anticipated launch of emerging therapies. The report provides detailed insights into current treatment practices, the pipeline of upcoming drugs, market shares of individual therapies, and forecasts the market size trajectory from 2019 to 2032 across the 7MM (the United States, EU-4 countries-Italy, Spain, France, and Germany-the United Kingdom, and Japan).

Discover the Anticipated Evolution and Growth of the Market @ Lumbosacral Radicular Pain Therapeutics Market Forecast [https://www.delveinsight.com/sample-request/lumbosacral-radicular-pain-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Therapeutic Advancements and Emerging Treatments:

*
Lumbosacral Radicular Pain Clinical Trial Progression: The market is poised for substantial growth, fueled by the anticipated launch of emerging therapies between 2023 and 2032. Leading companies such as Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, Inc., and Cephalon, among others, are actively working on innovative drugs for potential market introduction.

*
Lumbosacral Radicular Pain Innovative Therapies: Ongoing research and development efforts are paving the way for innovative therapies aimed at alleviating the signs and symptoms of lumbosacral radicular pain. Therapies such as SP-102 and Placulumab, among others, are playing a significant role in advancing the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Market Dynamics

In recent decades, research into lumbosacral radicular pain (LRP) has significantly increased. Low back pain (LBP) poses both a substantial medical challenge and a considerable economic burden worldwide. Despite growing efforts to manage LBP, its prevalence and associated disability continue to rise, making effective management of LRP a major concern for healthcare professionals.

When considering transforaminal Epidural Steroid Injections (ESIs), the use of particulate corticosteroids raises the risk of complications. Nonparticulate corticosteroids, often recommended as initial treatments, may provide only temporary relief and are sometimes formulated with neurotoxic preservatives. Enhancing the safety profile of ESIs could involve developing safer, sterile formulations that reduce complications while maintaining efficacy.

Several companies, including Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, Inc., and Cephalon, are actively working on new therapies to address the gaps in current treatments. The expanding range of developmental strategies, coupled with anticipated submissions to the US FDA, suggests that specialized therapies for LRP could emerge within the forecast period of 2021-2032. Additionally, a deeper understanding of the disease's pathogenesis is expected to drive the development of innovative treatments for lumbosacral radicular pain.

Request for a sample report @ https://www.delveinsight.com/sample-request/lumbosacral-radicular-pain-market [https://www.delveinsight.com/sample-request/lumbosacral-radicular-pain-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Leading Lumbosacral Radicular Pain Companies and Emerging Drugs: Leading companies such as Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, Inc., and Cephalon, among others, are actively working on developing innovative drugs for potential introduction into the lumbosacral radicular pain market.

Lumbosacral Radicular Pain Therapeutic Landscape: Notable therapies for treating lumbosacral radicular pain include SP-102, Placulumab, and others.

Lumbosacral Radicular Pain Overview:

Lumbosacral radicular pain is characterized by radiating discomfort that affects one or more lumbar or sacral dermatomes. This pain may be accompanied by additional radicular symptoms or reduced function. It can start acutely, often due to an injury, but has the potential to become chronic if not managed effectively. Early and appropriate management of the pain can help minimize both the duration and severity of symptoms.

The pain is generally categorized into three types: acute, chronic, and neuropathic. Each patient's experience of lumbar pain can vary, but common complaints associated with lumbar radiculopathy include pain, tingling, numbness, weakness, and loss of reflexes. These symptoms typically occur in the lower back, buttocks, legs, and feet. Although the pain may radiate to either leg, it usually affects only one leg.

Key Facts Lumbosacral Radicular Pain Market Report [https://www.delveinsight.com/report-store/lumbosacral-radicular-pain-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]:

*
Key players such as Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, Inc., and Cephalon, among others, are actively researching potential candidates for lumbosacral radicular pain.

*
The lumbosacral radicular pain pipeline features major therapies including SP-102, Placulumab, and others. Growing awareness is shaping the current therapeutic landscape across the 7MM. The market for lumbosacral radicular pain, valued at USD XX million in 2020, is projected to grow significantly by 2032.

*
According to BMUS: The Burden of Musculoskeletal Diseases in the United States, nearly 29% of the US population aged 18 and older self-reported experiencing lumbosacral radicular pain annually.

Lumbosacral Radicular Pain Epidemiology Segmentation:

*
According to Khorami et al. (2021), the annual prevalence of lumbosacral radicular pain-defined as low back pain with leg pain extending below the knee-ranges from 9.9% to 25% in the general population. The point prevalence varies between 4.6% and 13.4%, while the lifetime prevalence ranges from 1.2% to 43%. These figures suggest that lumbosacral radicular pain is likely one of the most common forms of neuropathic pain.

*
The report on lumbosacral radicular pain epidemiology includes both historical and projected data. It covers the total prevalence of lumbosacral radicular pain, the number of diagnosed and treatable cases, and prevalence segmented by age and gender. The analysis encompasses the 7MM (United States, EU4 countries-Germany, France, Italy, Spain-and the United Kingdom) and Japan, spanning from 2019 to 2032.

The Lumbosacral Radicular Pain market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

- Total Prevalence of Lumbosacral Radicular Pain

- Prevalent Cases of Lumbosacral Radicular Pain by severity

- Gender-specific Prevalence of Lumbosacral Radicular Pain

- Type-specific Prevalence of Lumbosacral Radicular Pain

- Age-specific Prevalence of Lumbosacral Radicular Pain

- Diagnosed Cases of Lumbosacral Radicular Pain

DelveInsight's comprehensive report provides a thorough exploration of the Lumbosacral Radicular Pain market, covering key Lumbosacral Radicular Pain players, emerging Lumbosacral Radicular Pain therapies, treatment dynamics, and market challenges.

Lumbosacral Radicular Pain Emerging Drugs

*
SP-102: Semnur Pharmaceuticals

For in-depth insights, access the full report @ Lumbosacral Radicular Pain Market Outlook 2032 [https://www.delveinsight.com/sample-request/lumbosacral-radicular-pain-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

DelveInsight's report offers comprehensive insights, market analysis, and forecasts aiding leading companies in strategic decision-making for the Lumbosacral Radicular Pain market landscapes

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lumbosacral-radicular-pain-market-growth-anticipated-by-2032-companies-includes-scilex-pharmaceuticals-inc-semnur-pharmaceuticals-teva-brandedpharmaceutical-products-rd-cephalon]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lumbosacral Radicular Pain Market Growth Anticipated by 2032 | Companies includes Scilex Pharmaceuticals, Inc., Semnur Pharmaceuticals, Teva BrandedPharmaceutical Products R&D, Cephalon here

News-ID: 3652425 • Views:

More Releases from ABNewswire

zSpace, Inc. (NASDAQ: ZSPC) Scales Immersive Learning Through Integrated AR, VR, and AI
zSpace, Inc. (NASDAQ: ZSPC) Scales Immersive Learning Through Integrated AR, VR, …
A classroom used to be four walls, a chalkboard, and a stack of books. Today it can be an operating room, a robotics lab, or the surface of Mars. What once required million-dollar equipment or dangerous experiments can now unfold safely on a desk. This transformation is not a thought experiment-it is happening right now through augmented and virtual reality platforms that merge curiosity with capability. At the center of
West Chester Showroom Reports Increased Interest in Sectional Couches and Affordable Home Furnishings
West Chester Showroom Reports Increased Interest in Sectional Couches and Afford …
Furniture & Cabinet Outlet serves West Chester's growing community with wholesale-priced home furnishings, offering extensive showroom selections and below-retail pricing for residents of the Tri-State area. West Chester Township, OH - As housing markets shift and homeowners seek affordable ways to refresh their living spaces, Furniture & Cabinet Outlet continues to serve the Tri-State area with wholesale-priced home furnishings. The Service Center Drive showroom has become a destination for residents searching
Beauty Shots NOVA Redefines Non-Surgical Body Contouring in Northern Virginia
Beauty Shots NOVA Redefines Non-Surgical Body Contouring in Northern Virginia
Founder Natascha Harris pioneers ultrasound-guided aesthetic treatments for safer, natural-looking results. Image: https://www.abnewswire.com/upload/2025/10/c5a5f59da37c1aa322df6881e23a4d74.jpg Vienna, VA - In an era where safety and results are equally vital in aesthetics, Beauty Shots NOVA, led by founder and aesthetic specialist Natascha Harris, is setting a new standard in non-surgical beauty care. Located at 8607 Westwood Center Dr, Suite 100 in Vienna, Virginia, the premier medspa is revolutionizing body contouring and cosmetic enhancement through ultrasound-guided procedures
Abby Yoga Studio Expands with Private Yoga Therapy Sessions
Abby Yoga Studio Expands with Private Yoga Therapy Sessions
Certified Yoga Therapy instructor offers tailored Iyengar-based practices for health needs. Image: https://www.abnewswire.com/upload/2025/10/f6b927744919d106273aa8b6f23c144c.jpg Abbotsford, BC - Abby Yoga Studio has introduced private yoga therapy sessions, focusing on personalized assessments and adapted practices for individuals or small groups. Applying Iyengar yoga therapy principles, these one-on-one or limited-group classes address physical and emotional challenges, integrating mind-body healing to restore natural function. Led by Eileen Millar, a Level Three certified Iyengar teacher and C-IAYT yoga therapist,

All 5 Releases


More Releases for Lumbosacral

Lumbosacral Radicular Pain Market is expected to reach $11.7 billion by 2034
Lumbosacral radicular pain, commonly referred to as sciatica, is a neuropathic pain condition caused by compression or irritation of the lumbosacral nerve roots. It typically results from herniated discs, lumbar spinal stenosis, degenerative disc disease, or trauma, and is characterized by sharp radiating pain, numbness, tingling, or weakness in the lower back and legs. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71947 The condition significantly impacts quality of life and
2025-2034 Lumbosacral Radicular Pain Management Market Roadmap: Insights for Com …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Acne Treatments Market Size By 2025? In recent times, the acne treatments market has experienced a robust growth. The projection is that it will expand from $8.29 billion in 2024 to $8.81 billion in 2025, representing a compound annual growth rate (CAGR) of 6.3%. The
Comprehensive 2025 Lumbosacral Radicular Pain Market Overview: Trends, Forecasts …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Lumbosacral Radicular Pain Market Through 2025? The market for lumbosacral radicular pain has seen significant growth in the past few years. It is predicted to increase from $0.91 billion in 2024 to $0.97 billion in 2025, with a Compound Annual Growth Rate
Lumbosacral Radicular Pain Market is Expected to Show a Healthy Growth Rate Duri …
DelveInsight's "Lumbosacral Radicular Pain- Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the lumbosacral radicular pain, historical and forecasted epidemiology as well as the lumbosacral radicular pain market trends in the United States, EU4 (Germany, France, Italy, Spain) and United Kingdom, and Japan. Download Sample Report to know more @ https://www.delveinsight.com/sample-request/lumbosacral-radicular-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr Lumbosacral Radicular Pain Overview Lumbosacral radiculopathy is a disorder that causes pain in the lower back
Lumbosacral Radicular Pain Treatment Market 2023 | COVID-19 Impact Analysis Repo …
Worldwide Market Reports published a "Lumbosacral Radicular Pain Treatment Market Business Growth Forecast 2023-2030" report that sheds light on the key opportunities attributing to the growth of the market. This Insight Report offers a thorough study of the global Lumbosacral Radicular Pain Treatment market and identifies significant trends in product/services segmentation, company formation, revenue, market share, recent advancements, and M&A activity. With a focus on Lumbosacral Radicular Pain Treatment portfolios
Lumbosacral Radicular Pain Treatment Market 2023 Analysis of Rising Business Opp …
Global Lumbosacral Radicular Pain Treatment Market 2023 is expected to experience robust growth, offering market players a profitable opportunity to expand their presence in acknowledging economies and increase their revenue streams. To strengthen their position and enhance their market share, companies can leverage this growth potential. To conduct a thorough analysis of the global Lumbosacral Radicular Pain Treatment Market, several crucial factors were considered, including segmentation analysis, current trends, potential